Susquehanna International Group’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,602
Closed -$13.6K 13618
2026
Q1
$13.6K Buy
+13,602
New +$13.1K ﹤0.01% 12905
2023
Q2
Sell
-17,282
Closed -$5.65K 12276
2023
Q1
$5.65K Sell
17,282
-10,718
-38% -$4.06K ﹤0.01% 12292
2022
Q4
$7K Buy
+28,000
New +$8.57K ﹤0.01% 11995

Other funds holding DRTSW

Susquehanna International Group's DRTSW Position: Q2 2026 in Review

Susquehanna International Group sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2026, closing a stake of 13,602 shares — an estimated $13.6K sold.

Susquehanna International Group first reported a position in DRTSW in Q4 2022 and held it in 3 quarters. The position peaked at $13.6K in Q1 2026. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Susquehanna International Group reported no remaining Alpha Tau Medical Warrant position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 13,602 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $13.6K.
  • Susquehanna International Group first reported a position in Alpha Tau Medical Warrant in Q4 2022 and held it in 3 quarters.
  • Susquehanna International Group's Alpha Tau Medical Warrant position peaked at $13.6K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.